In a rapidly evolving healthcare landscape, few organizations have navigated growth and innovation as gracefully and effectively as Healthmap Solutions. In a recent episode of the American Journal of Healthcare Strategy podcast, host Cole sat down with Tom Gaffney, Chief Growth Officer at Healthmap Solutions, to discuss the company's unique approach to kidney population health management, its strategic use of advanced technology, and how early identification and intervention in chronic kidney disease (CKD) has paved the way for remarkable expansion. By sharing insights on the company's recent acquisition of Carium and reflecting on real-world success stories—most notably in Puerto Rico—Gaffney showcased a blueprint that resonates not only with players in the CKD space but also with leaders across the broader healthcare sector.
Since its inception in 2013 and first client launch in 2016, Healthmap Solutions has steadfastly pursued one overarching aim: put patients first. While many healthcare organizations use technology and AI as selling points, Healthmap views these as tools to enhance human-centered care rather than as standalone solutions. Gaffney explained:
"We are very much focused on using AI where AI is important, but … there's a lot of other things that need to occur and need to happen for success."
In other words, Healthmap Solutions works to ensure that predictive analytics, digital engagement, and data-driven insights complement what is fundamentally an empathetic, hands-on model. This approach emphasizes the importance of patient experience and whole-person care. Or, as Gaffney succinctly put it:
"Being compassionate, providing empathy, working first and foremost on behalf of the patient … the rest of the business takes care of itself."
By emphasizing compassion and consistent patient engagement over marketing buzzwords, the company builds meaningful relationships with health plans, provider groups, and especially members—people navigating often-challenging CKD journeys.
One of the most significant differentiators in Healthmap Solutions' approach is its commitment to managing CKD from its early stages. Instead of centering their efforts only on patients who already require renal replacement therapy (end-stage renal disease, or ESRD), they direct focused care to those identified at earlier stages, including CKD stages 3 and 4. Gaffney underscored the crucial rationale behind this early identification strategy:
"We continue to be very much focused on population health and on moving upstream in the disease state progression … if you're truly going to slow the progression of the disease, and sometimes try to avoid [the late-stage outcomes], the only way you're going to do that is to get with the patient early."
By intervening upstream, Healthmap is better able to manage comorbidities—like diabetes and hypertension—that commonly accompany kidney disease. This holistic perspective ensures that members receive comprehensive, personalized care plans that don't simply treat CKD in isolation. The result? Improved clinical outcomes, enhanced quality scores, and a measurable decrease in the overall cost of care for payors.
Achieving national reach while keeping care personalized is a tall order. Yet Healthmap Solutions has methodically expanded its footprint, now serving 43 states and on track to cover all 50 by the end of 2023. How did the company scale so strategically? According to Gaffney, it was a balancing act between measured caution and seizing prime market opportunities. He describes the early phases of the organization's expansion:
"We wanted to make sure that we were being slow enough that we were going to be able to effectively implement our program and ensure that it was delivering on … providing savings, driving outcomes, [and] ensuring high NPS scores."
This blend of meticulous planning and swift execution has allowed Healthmap Solutions to scale without sacrificing the quality and empathy that underpin its service model. The company carefully selects the right types of health plans, health systems, and accountable care organizations (ACOs) that share its commitment to value-based solutions. In some cases, this involves full-risk and capitated models, where Healthmap assumes—and skillfully manages—the financial risk for kidney care costs.
"We started off early on with an ASO-based model … but in 2023, we established our model and began talking about full risk and capitated models with our clients."
For Healthmap solutions, embracing downside risk was not taken lightly. Rather, it was a clear indication that its quality-driven methodology and proven outcomes would translate to successful financial arrangements, ultimately leading to improved outcomes and reduced total medical costs.
One of the most notable inflection points in Healthmap Solutions' trajectory came through its acquisition of Carium health, a digital health company that brings cutting-edge artificial intelligence, predictive analytics, and remote patient monitoring capabilities to the table. While Healthmap had long possessed a robust proprietary platform, known as Compass, the addition of Carium's expertise means the company can further refine predictive models that incorporate comorbidities and multiple risk factors, rather than focusing on a single disease progression model.
"Take what we've shared about all that information we have in Compass, and now marry that with what we're going to have with Carium … We really have a lot of opportunity for providers, our patients, and our customers."
The end goal remains the same: offer human-centered, empathetic care that leverages advanced technology in more meaningful ways. Yet by enhancing digital engagement and extending the reach of clinical teams, Healthmap can touch more lives, improve care coordination, and support members wherever they are—through virtual care management or in-person visits.
In healthcare, local context matters. The success of a CKD management program in Texas might rely on entirely different dynamics than one in New York or Puerto Rico. Healthmap Solutions demonstrates how a national presence still depends on local trust and cultural alignment. Their foray into Puerto Rico illustrates this principle vividly:
"When we closed the business on triple-S, Blue Cross Blue Shield of Puerto Rico, we had to very quickly set up a service center and hire a strong group of individuals. … We built culture, we had to make sure we could build trust … Healthcare is local."
The result was a deep connection with the Puerto Rican community, reflected in stories such as a team member who thanked Gaffney for delivering a CKD management program that her own family needed. "I have three family members that are in stage renal disease … Healthmap now can help me help my family get better," she told him. Such accounts underscore how potent local, in-person presence can be for driving tangible results.
As Gaffney explained, launching in Puerto Rico was like "onboarding on steroids," involving more than 80 local hires and establishing new infrastructure virtually overnight. Yet the painstaking attention to cultural nuances and relationship-building has already paid off in glowing testimonials and a surge of interest from new customers on the island.
For years, the healthcare industry has talked about moving from fee-for-service to value-based care, but few have consistently demonstrated the operational excellence and patient outcomes that make full-risk or capitated models truly viable. Healthmap Solutions is a standout exception. It has carefully woven advanced technology, early intervention, robust analytics, and compassionate care into a tapestry of success stories.
According to Gaffney, a major driver of this success has been the executive leadership team's collective background, which includes extensive experience at health plans and leading organizations such as Magellan, WellCare, and Centene. This inside knowledge allows Healthmap to offer more than a product; it offers a partnership that "meets plans where they are," whether that means risk-based contracts or regionally targeted rollouts.
"Every customer isn't a good customer for Healthmap … we were very clear on what types of health plans we wanted to work with … and we assessed the geographical footprint for an easy go-live."
By aligning the right payor mix with robust local engagement, Healthmap Solutions not only achieves better clinical outcomes for CKD members but also drives better quality ratings and cost savings for its clients. This approach has proven particularly effective in managing high-risk populations and delivering complex care management solutions.
Healthmap Solutions shows no signs of slowing down. With an ambition to cover all 50 states by the year's end and a projected surge to well over 200,000 kidney members under management, the company's upward trajectory continues. New markets, technologies, and even more sophisticated risk-based models lie on the horizon. Gaffney hinted at these expansions:
"You will see some pretty big improvements as it relates to our footprint … By the end of this year, we'll have all states covered … We'll go north of 200,000 kidney members and then some."
Such growth is driven by the same principles that have guided Healthmap from the start: empathetic care, strategic partnerships, and responsible risk management. It's also powered by a deep commitment to employing technology the right way, harnessing AI and predictive analytics to inform clinical decision-making rather than replace it.
The path Healthmap Solutions has charted is instructive for a wide range of industries and entrepreneurs. From a business perspective, it's a masterclass in scaling methodically, maintaining product (or service) integrity, and leveraging advanced technology without losing sight of the human element. In healthcare specifically, it's a beacon illustrating the viability of value-based solutions when combined with strategic market entry, local engagement, and a data-driven, holistic approach to patient health.
"If we can be known for being compassionate, providing empathy, working first and foremost on behalf of the patient, you know, the rest of the business takes care of itself."
That philosophy, coupled with innovations in AI and a relentless focus on early identification and intervention, has carried Healthmap Solutions to the forefront of CKD management. From 43 states to all 50, from selective partnerships to full-scale risk-taking, and from risk to reward—the company's momentum not only testifies to its own resilience but also offers a roadmap for anyone striving to transform healthcare for the better. With its dedicated care navigation team, focus on planned dialysis starts, and commitment to reducing total medical costs, Healthmap Solutions continues to set the standard for kidney care management in the United States.
